Support
Vijayanand
Cancer Immunology

  In 2013, Dr. Vijayanand teamed up with Professor Christian Ottensmeier at the Cancer Center, University of Southampton, UK, to

READ MORE
Sharma
Targeting Tumor Endothelium for Cancer Surveillance and Immunotherapy

Preliminary data from our lab shows that vascular endothelial cells (vECs) mount remarkably potent innate responses to cell-free DNA, which

READ MORE
Sharma
New Molecular Players in the cGAS-STING Pathway of Anti-Viral and Anti-Tumor Defense

Cell-free, immuno-stimulatory DNA is recognized in the cytoplasm of cells as a universal danger signal by the innate immune system.

READ MORE
Peters
Cancer

Immunotherapies for head and neck cancer: To develop new cancer therapies by studying how the immune system, by way of

READ MORE
Hedrick
Immunoprofiling of Human Immune Cells in Cardiovascular Disease and Cancer

READ MORE
Cheroutre
CD4+ Cytotoxic Lymphocytes

MHC class-II restricted CD4+ T cytotoxic cells (CD4 CTL) are among the best examples of extreme measures the immune system

READ MORE
Altman
A Novel CTLA4-Mediated Treg Cell-Intrinsic Signaling Pathway

Recent work by others has provided evidence that, in contrast to conventional T cells, PKCq negatively regulates the suppressive activity

READ MORE
Vijayanand Lab
Pandurangan Vijayanand, M.D., Ph.D.
Associate Professor
William K. Bowes Distinguished Professor, Center for Autoimmunity and Inflammation, Center for Cancer Immunotherapy

Pandurangan Vijayanand, M.D., Ph.D., and his lab members employ genomics tools to understand, diagnose and treat pulmonary disease such as asthma, lung cancer and infectious diseases, including the novel coronavirus.

Read More
Sharma Lab
Sonia Sharma, Ph.D.
Associate Professor
Center for Autoimmunity and Inflammation, Center for Cancer Immunotherapy

Sonia Sharma, Ph.D., and her lab members lead unbiased, genome-scale approaches to unravel innate immunity, the body’s early immune response to microbial pathogens and neoplastic cells.

Read More
Schoenberger Lab
Stephen Schoenberger, Ph.D.
Professor
Center for Cancer Immunotherapy

Stephen Schoenberger, Ph.D., is focused on achieving a mechanistic understanding of the generation and regulation of T cell responses in the context of in vivo infection and tumor development.

Read More
Load More